Responsiveness of function scales in hip and knee OA
| Baseline Mean score±SD | Final Mean score±SD | Mean change±SD | SRM 95% CI | Effect size 95% CI | |
|---|---|---|---|---|---|
| Knee OA | |||||
| Patient NRS (0–10) | 5.93±1.92 | 4.12±2.15 | 1.81±2.2 | 0.83 (0.82 to 0.84) | 0.89 (0.88 to 0.89) |
| Physician NRS (0–10) | 5.43±1.70 | 3.74±1.92 | 1.69±2.1 | 0.80 (0.79 to 0.81) | 1.08 (1.07 to 1.09) |
| WOMAC function (0–100) | 46.0±16.4 | 35.5±18.8 | 10.5±16.4 | 0.64 (0.63 to 0.65) | 0.66 (0.65 to 0.66) |
| Hip OA | |||||
| Patient NRS (0–10) | 5.69±2.04 | 4.23±2.19 | 1.46±2.0 | 0.73 (0.72 to 0.74) | 0.64 (0.63 to 0.65) |
| Physician NRS (0–10) | 5.41±1.77 | 4.14±2.10 | 1.27±2.0 | 0.64 (0.63 to 0.65) | 0.84 (0.83 to 0.85) |
| WOMAC function (0–100) | 47.0±16.4 | 39.7±17.0 | 7.3±14.9 | 0.49 (0.47 to 0.51) | 0.45 (0.44 to 0.46) |
Patients were evaluated before and 1 month after treatment with NSAIDs.
NRS, numerical rating scale; NSAIDs, non-steroids anti-inflammatory drugs; OA, osteoarthritis; SRM, standardised response mean; WOMAC, Western Ontario and McMaster Universities osteoarthritis index.